First Trust Advisors LP Acquires 1,778,475 Shares of Kenvue Inc. $KVUE

First Trust Advisors LP raised its stake in shares of Kenvue Inc. (NYSE:KVUE) by 200.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,667,217 shares of the company’s stock after buying an additional 1,778,475 shares during the quarter. First Trust Advisors LP owned about 0.14% of Kenvue worth $43,289,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. Norges Bank bought a new position in shares of Kenvue during the second quarter worth $537,418,000. Independent Franchise Partners LLP grew its stake in Kenvue by 233.4% during the second quarter. Independent Franchise Partners LLP now owns 31,265,574 shares of the company’s stock valued at $654,388,000 after acquiring an additional 21,886,537 shares in the last quarter. American Century Companies Inc. increased its holdings in Kenvue by 38.6% in the 2nd quarter. American Century Companies Inc. now owns 30,265,020 shares of the company’s stock valued at $633,447,000 after acquiring an additional 8,436,166 shares during the last quarter. Amundi increased its holdings in Kenvue by 82.5% in the 2nd quarter. Amundi now owns 14,509,890 shares of the company’s stock valued at $305,446,000 after acquiring an additional 6,559,261 shares during the last quarter. Finally, Mondrian Investment Partners LTD purchased a new stake in Kenvue in the 3rd quarter worth $79,269,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on KVUE shares. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a research report on Friday, January 9th. Citigroup boosted their target price on Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 18th. Argus raised Kenvue to a “hold” rating in a research note on Friday, March 6th. Barclays raised their price target on Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a report on Friday, March 6th. Finally, Zacks Research raised Kenvue from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. Three research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company’s stock. According to MarketBeat.com, Kenvue presently has an average rating of “Hold” and a consensus price target of $19.58.

Kenvue Stock Performance

Kenvue stock opened at $17.38 on Friday. The company’s 50-day moving average price is $17.89 and its 200-day moving average price is $17.35. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66. The company has a market cap of $33.30 billion, a PE ratio of 22.56, a price-to-earnings-growth ratio of 4.01 and a beta of 0.51. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $25.17.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. The firm had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $3.68 billion. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The firm’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.26 EPS. On average, equities research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were given a dividend of $0.2075 per share. The ex-dividend date was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a yield of 4.8%. Kenvue’s dividend payout ratio is 107.79%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.